Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Pfizer sweetens bid for AstraZeneca to USD117 billion

19th May 2014 05:38

New York (Alliance News) - US pharmaceutical firm Pfizer Inc is mounting another attempt to take over British competitor AstraZeneca PLC, the company said Sunday.

A bid of 117 billion dollars is the final offer, Pfizer said, after previous offers had been rejected by AstraZeneca management.

"We have tried repeatedly to engage in a constructive process with AstraZeneca," Pfizer chief executive Ian Read said.

"Following a conversation with AstraZeneca earlier today, we do not believe that the AstraZeneca board is currently prepared to recommend a deal at a reasonable price. We remain ready to engage in a meaningful dialogue but time for constructive engagement is running out."

AstraZeneca employs 50,000 people worldwide, including 6,700 in Britain. Pfizer's workforce of 70,000 includes 2,500 in Britain. A previous offer of 106 billion dollars was turned down.

Copyright dpa


Related Shares:

Astrazeneca
FTSE 100 Latest
Value8,417.34
Change2.09